Press Release:*MiMedx® Group Announces Positive Results From Diabetic Foot Ulcer Randomized Controlled Trial*—Quote—MiMedx Group, Inc., an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane,… More..
Read more here:
EpiFix for diabetic foot ulcers